+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Octapharma AG - logo

Octapharma is a privately-owned global human proteins manufacturer headquartered in Lachen, Switzerland. It develops human proteins that are derived from human plasma and human cell-lines. The company provides biopharmaceutical products and therapies for haematology, intensive care & emergency medicine, and immunotherapy. Octapharma owns and operates six state of the art plants, employing over 6,000 workers globally. It was founded in 1983 by Wolfgang Marguerre.

From
From
From
From
Global Markets for Bioengineered Protein Drugs - Product Thumbnail Image

Global Markets for Bioengineered Protein Drugs

  • Report
  • March 2023
  • 185 Pages
  • Global
From
Blood Plasma Derivatives Global Market Report 2024 - Product Thumbnail Image

Blood Plasma Derivatives Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Hemophilia Global Market Report 2024 - Product Thumbnail Image

Hemophilia Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
From
Bleeding Disorders Treatment Global Market Report 2024 - Product Thumbnail Image

Bleeding Disorders Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
From
Loading Indicator